Paolo Fagone Selected Research

Paolo Fagone Research Topics

Disease

19	Neoplasms (Cancer) 01/2022 - 03/2011
13	Multiple Sclerosis 01/2021 - 06/2013
7	Autoimmune Diseases (Autoimmune Disease) 01/2021 - 06/2013
6	COVID-19 01/2022 - 07/2020
6	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020 - 06/2013
5	Inflammation (Inflammations) 01/2021 - 05/2011
5	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/2021 - 05/2011
4	Infections 01/2021 - 09/2011
4	Neuroblastoma 03/2020 - 10/2015
4	Melanoma (Melanoma, Malignant) 01/2019 - 08/2012
3	Autoimmune Hepatitis 09/2020 - 11/2015
3	Prostatic Neoplasms (Prostate Cancer) 01/2013 - 02/2011
2	Cognitive Dysfunction 02/2022 - 01/2021
2	Alzheimer Disease (Alzheimer's Disease) 02/2022 - 01/2020
2	Neuroinflammatory Diseases 07/2021 - 01/2012
2	Drug-Related Side Effects and Adverse Reactions 01/2021 - 11/2020
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 01/2021 - 11/2019
2	Major Depressive Disorder (Major Depressive Disorders) 05/2020 - 01/2020
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 11/2019 - 10/2015
2	Rheumatoid Arthritis 11/2019 - 08/2014
2	Glioblastoma (Glioblastoma Multiforme) 09/2018 - 04/2018
2	Parkinson Disease (Parkinson's Disease) 01/2012 - 08/2011
1	Dementia (Dementias) 02/2022
1	Virus Diseases (Viral Diseases) 08/2021
1	Chronic Pain 01/2021
1	Muscular Diseases (Myopathy) 01/2021
1	Discoid Lupus Erythematosus 01/2021
1	Cytokine Release Syndrome 11/2020
1	Autism Spectrum Disorder 10/2020
1	Liver Cirrhosis (Hepatic Cirrhosis) 09/2020
1	Fibrosis (Cirrhosis) 09/2020
1	Thromboembolism 09/2020
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 09/2020
1	Disseminated Intravascular Coagulation 09/2020

Drug/Important Bio-Agent (IBA)

13	CytokinesIBA 01/2021 - 01/2012
12	Macrophage Migration-Inhibitory FactorsIBA 01/2021 - 08/2011
8	Pharmaceutical PreparationsIBA 01/2021 - 02/2011
7	saquinavir-NOIBA 01/2017 - 02/2011
6	Proteins (Proteins, Gene)FDA Link 01/2021 - 03/2009
4	Antiviral Agents (Antivirals)IBA 01/2022 - 10/2012
4	dopachrome isomeraseIBA 01/2021 - 10/2019
4	DDTIBA 01/2021 - 10/2019
3	Biomarkers (Surrogate Marker)IBA 01/2022 - 07/2019
3	Biological ProductsIBA 07/2020 - 09/2018
3	Decitabine FDA Link 11/2019 - 12/2014
3	HIV Protease InhibitorsIBA 01/2017 - 10/2015
3	Saquinavir (Invirase)FDA Link 10/2012 - 02/2011
2	AntioxidantsIBA 02/2022 - 08/2021
2	TOR Serine-Threonine KinasesIBA 01/2022 - 08/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2021 - 11/2020
2	Hormones (Hormone)IBA 01/2021 - 02/2011
2	Interleukin-2 (IL2)IBA 01/2021 - 09/2013
2	LipopolysaccharidesIBA 11/2020 - 08/2014
2	Concanavalin AIBA 09/2020 - 01/2018
2	EnzymesIBA 07/2020 - 09/2011
2	Myelin-Oligodendrocyte GlycoproteinIBA 01/2020 - 09/2019
2	TetraspaninsIBA 01/2020 - 09/2019
2	InterleukinsIBA 12/2019 - 01/2012
2	Interleukin-17 (Interleukin 17)IBA 01/2018 - 06/2013
2	sodium boranocarbonateIBA 01/2018 - 04/2015
2	Heme Oxygenase-1IBA 01/2018 - 08/2013
2	AntigensIBA 01/2017 - 12/2012
2	Cyclin D1IBA 10/2015 - 10/2015
2	Acetic Acid (Vinegar)FDA LinkGeneric 08/2014 - 10/2012
2	MTOR InhibitorsIBA 01/2013 - 10/2012
2	Antineoplastic Agents (Antineoplastics)IBA 12/2012 - 08/2012
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2012 - 02/2011
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2012 - 03/2011
2	Protease Inhibitors (Protease Inhibitor)IBA 08/2012 - 02/2011
2	17-triol 7 17-ethynyl-5-androstene-3IBA 01/2012 - 05/2011
1	Neuroprotective AgentsIBA 02/2022
1	Scopolamine (Hyoscine)FDA Link 02/2022
1	Cholinergic Agents (Cholinergics)IBA 02/2022
1	myrtenalIBA 02/2022
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2022
1	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2022
1	Transcription Factors (Transcription Factor)IBA 11/2021
1	Thioctic Acid (Lipoic Acid)IBA 08/2021
1	LectinsIBA 07/2021
1	Galectins (Galectin)IBA 07/2021
1	Biological FactorsIBA 01/2021
1	Chemokine CXCL13IBA 01/2021
1	Chemokine CCL5IBA 01/2021
1	DystrophinIBA 01/2021
1	Interleukin-4 (Interleukin 4)IBA 01/2021
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021
1	Interleukin-12 (IL 12)IBA 01/2021
1	AntibodiesIBA 01/2021
1	sodium luminolateIBA 11/2020
1	RNA (Ribonucleic Acid)IBA 10/2020
1	Imatinib Mesylate (Gleevec)FDA Link 09/2020
1	Angiogenesis InhibitorsIBA 09/2020
1	Sorafenib (BAY 43-9006)FDA Link 09/2020
1	Drug CombinationsIBA 09/2020
1	Dacarbazine (DIC)FDA LinkGeneric 09/2020
1	GYY 4137IBA 07/2020
1	Hydrogen Sulfide (Sulfide, Hydrogen)IBA 07/2020

Therapy/Procedure

8	Therapeutics 07/2020 - 03/2011
2	Immunotherapy 08/2019 - 01/2017
2	Oral Administration 01/2017 - 01/2012